File(s) not publicly available
The many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders
Version 2 2024-06-05, 05:05
Version 1 2023-10-25, 23:41
journal contribution
posted on 2024-06-05, 05:05 authored by G Morris, AF Carvalho, G Anderson, P Galecki, M MaesThe many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders
History
Journal
Current Pharmaceutical DesignVolume
22Pagination
963-977Location
Sharjah, United Arab EmiratesPublisher DOI
ISSN
1381-6128eISSN
1873-4286Language
engPublication classification
C1 Refereed article in a scholarly journalIssue
8Publisher
BenthamUsage metrics
Categories
No categories selectedKeywords
ARYL-HYDROCARBON RECEPTORBLOOD-BRAIN-BARRIERCHAIN AMINO-ACIDSchronic fatigueENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROMEEXTRACELLULAR DOPAMINE LEVELSFACTOR-KAPPA-BimmuneINCREASED INDOLEAMINE 2,3-DIOXYGENASEinflammationINHIBITS GLUTAMATE UPTAKEKYNURENINE PATHWAY METABOLISMleaky gutLife Sciences & Biomedicineoxidative and nitrosative stressPharmacology & PharmacyPLASMACYTOID DENDRITIC CELLSSchizophreniaScience & Technology
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC